FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, more specifically to use of peptide, consisting of at least 8 consecutive amino acid residues of the sequence set forth in SEQ ID NO: 3, for diagnosing multiple sclerosis, that can be used in medicine. Multiple sclerosis or a predisposition for multiple sclerosis in a subject are being diagnosed in case an anti-KIR4.1 antibody is present in the patient's sample.
EFFECT: invention enables to obtain alternative means and methods for diagnosing and/or treating multiple sclerosis.
9 cl, 8 dwg, 1 tbl, 6 ex
Authors
Dates
2016-10-27—Published
2012-05-23—Filed